Trends in Neurosciences
The mGluR theory of fragile X mental retardation
Section snippets
From long-term synaptic depression to fragile X
Synaptic activity in the brain can trigger long-lasting changes in synaptic strength called long-term potentiation (LTP) and long-term depression (LTD). In neonates, the mechanisms of LTP seem to be important for retaining nascent synapses, whereas LTD mechanisms seem to be important for activity-guided synapse elimination. These same mechanisms, working in concert, contribute to learning and memory storage throughout postnatal life [14].
Understanding the mechanisms and functional significance
Emerging functions of FMRP
FMRP has been the subject of several recent reviews 3, 35, 36, 37. The excitement stems in part from the fact that fragile X syndrome is caused by a defect in a single gene, so understanding the function of the missing protein promises to provide insight into the pathophysiology of mental retardation, as well as cognition in general. However, the other reason for sudden interest is that FMRP has proven to be a fascinating molecule; it has captured the attention of neurobiologists interested in
Emerging functions of Gp1 mGluR-stimulated protein synthesis
It has been recognized for many years that the machinery for protein synthesis is present in the dendrites of cortical neurons near synapses 53, 54. Translation of pre-existing mRNAs can be activated in different ways by different signals (e.g. TrkB and NMDA receptor activation), but it is now very clear that activation of Gp1 mGluRs is a potent stimulus for local protein synthesis 52, 55, 56. Moreover, in cases where it has been specifically examined, many functional consequences of Gp1 mGluR
The mGluR theory of fragile X mental retardation
Our studies in the Fmr1 knockout mouse led us to suggest that exaggerated LTD could slow net synaptic maturation (by tipping the balance away from synapse gain towards synapse loss during the critical period of synaptogenesis), and therefore contribute to the developmental delay and cognitive impairment associated with fragile X (Figure 2b). However, FMRP is widely expressed in the brain, including most, if not all, neurons that express Gp1 mGluRs. We therefore considered the possibility that
Predictions and progress
A theory can be tested in two ways: (i) assessing the validity of the underlying assumptions, and (ii) spinning out their consequences [91]. The follow-up Banbury meeting in 2003 revealed that such tests are underway in several laboratories, in addition to our own. It is premature to report on these studies, but we can make some explicit predictions.
The first assumption suggests that many of the long-lasting responses to Gp1 mGluR activation will prove to be protein synthesis dependent. In the
Prospects for treatment of fragile X syndrome with Gp1 mGluR antagonists
The theory portrayed in Figure 3(a) suggests that it might be possible to overcome the loss of FMRP by dampening the protein synthesis triggered by activation of Gp1 mGluRs – this is the conceptual basis for the use of mGluR antagonists to reverse the fragile X phenotype. However, two caveats must be considered.
First, as mentioned previously, recent research suggests that although some proteins are overexpressed in the absence of FMRP (e.g. Arc and MAP1b) [44], others appear to be
Beyond fragile X
There is a great deal left to be learned about how protein synthesis is regulated by, and in turn influences, synaptic transmission in the brain. However, two things are certain: (i) FMRP is only one of many proteins and signaling pathways involved in the synaptic regulation of protein synthesis, and (ii) where there is biology, there is pathology. If we are correct that key aspects of fragile X are due to unregulated synaptic protein synthesis, it seems reasonable to anticipate that other
Acknowledgements
Supported in part by grants from FRAXA Research Foundation and the National Institute for Child Health and Human Development. We thank Mike Tranfaglia and Gül Dolen for helpful comments on the manuscript.
References (95)
Antibodies inactivating mGluR1 metabotropic glutamate receptor block long-term depression in cultured Purkinje cells
Neuron
(1994)Two distinct forms of long-term depression coexist in CA1 hippocampal pyramidal cells
Neuron
(1997)Phosphorylation of the AMPA receptor GluR1 subunit is required for synaptic plasticity and retention of spatial memory
Cell
(2003)- et al.
Induction of LTD in the adult hippocampus by the synaptic activation of AMPA/kainate and metabotropic glutamate receptors
Neuropharmacology
(1999) - et al.
Anisomycin inhibits the late maintenance of long-term depression in rat hippocampal slices in vitro
Neurosci. Lett.
(2003) Fragile X mouse: strain effects of knockout phenotype and evidence suggesting deficient amygdala function
Neuroscience
(1999)- et al.
New insights into fragile X syndrome: from molecules to neurobehaviors
Trends Biochem. Sci.
(2003) - et al.
Sunrise at the synapse: the FMRP mRNP shaping the synaptic interface
Neuron
(2003) FMRP associates with polyribosomes as an mRNP, and the I304N mutation of severe fragile X syndrome abolishes this association
Mol. Cell
(1997)Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome
Cell
(2001)
Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function
Cell
RNA cargoes associating with FMRP reveal deficits in cellular functioning in Fmr1 null mice
Neuron
The fragile X mental retardation protein binds and regulates a novel class of mRNAs containing U rich target sequences
Neuroscience
The fragile X syndrome protein FMRP associates with BC1 RNA and regulates the translation of specific mRNAs at synapses
Cell
Drosophila fragile X-related gene regulates the MAP1B homolog Futsch to control synaptic structure and function
Cell
Compartmentalized synthesis and degradation of proteins in neurons
Neuron
The group I mGlu receptor agonist DHPG induces a novel form of LTD in the CA1 region of the hippocampus
Neuropharmacology
Metabotropic glutamate receptor activation causes a rapid redistribution of AMPA receptors
Neuropharmacology
Altered presynaptic vesicle release and cycling during mGluR-dependent LTD
Neuron
Cell type and pathway dependence of synaptic AMPA receptor number and variability in the hippocampus
Neuron
The basal ganglia and chunking of action repertoires
Neurobiol. Learn. Mem.
Corticostriatal LTP requires combined mGluR1 and mGluR5 activation
Neuropharmacology
Anticonvulsant activity of two metabotropic glutamate group I antagonists selective for the mGlu5 receptor: 2-methyl-6-(phenylethynyl)-pyridine (MPEP), and (E)-6-methyl-2-styryl-pyridine (SIB 1893)
Neuropharmacology
Fragile X mice develop sensory hyperreactivity to auditory stimuli
Neuroscience
Alterations in the auditory startle response in Fmr1 targeted mutant mouse models of fragile X syndrome
Brain Res.
mGlu5 receptors and nociceptive function II. mGlu5 receptors functionally expressed on peripheral sensory neurones mediate inflammatory hyperalgesia
Neuropharmacology
Drosophila fragile X protein, DFXR, regulates neuronal morphology and function in the brain
Neuron
Drosophila lacking dfmr1 activity show defects in circadian output and fail to maintain courtship interest
Neuron
A role for the Drosophila fragile X-related gene in circadian output
Curr. Biol.
Novel allosteric antagonists shed light on mglu(5) receptors and CNS disorders
Trends Pharmacol. Sci.
A decade of molecular studies of fragile X syndrome
Annu. Rev. Neurosci.
The physical and behavioral phenotype
Understanding fragile X syndrome: insights from animal models
Cytogenet. Genome Res.
Adult fragile X syndrome. Clinico-neuropathologic findings
Acta Neuropathol. (Berl.)
Analysis of neocortex in three males with the fragile X syndrome
Am. J. Med. Genet.
Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: a quantitative examination
Am. J. Med. Genet.
Dendritic spine ‘dysgenesis’ and mental retardation
Science
Dendritic anomalies in disorders associated with mental retardation
Cereb. Cortex
Fmr1 knockout mice: a model to study fragile X mental retardation. The Dutch–Belgian fragile X consortium
Cell
Of mice and the fragile X syndrome
Trends Genet.
Abnormal development of dendritic spines in FMR1 knock-out mice
J. Neurosci.
Dendritic spine and dendritic field characteristics of layer V pyramidal neurons in the visual cortex of fragile-X knockout mice
Am. J. Med. Genet.
Altered synaptic plasticity in a mouse model of fragile X mental retardation
Proc. Natl. Acad. Sci. U. S. A.
The role of LTD and LTP in development and learning
Climbing fibre induced depression of both mossy fibre responsiveness and glutamate sensitivity of cerebellar Purkinje cells
J. Physiol.
Long term depression
Homosynaptic long-term depression in area CA1 of hippocampus and effects of N-methyl-d-aspartate receptor blockade
Proc. Natl. Acad. Sci. U. S. A.
Cited by (1335)
Bisphenol F affects neurodevelopmental gene expression, mushroom body development, and behavior in Drosophila melanogaster
2024, Neurotoxicology and TeratologyFMRP phosphorylation modulates neuronal translation through YTHDF1
2023, Molecular Cell